What’s next for hot biotech stock Viking Therapeutics? Here’s how the company can scale up.
Viking’s obesity-drug program is progressing well. Now management is thinking about manufacturing tie-ups.
Trump rolls back effort to lower Medicare, Medicaid drug costs
Trump’s executive order halts an effort to cap the copayment for generic medications at $2 for Medicare beneficiaries.
Tennis player Eva Lys didn’t originally qualify for the Australian Open — but went on to win almost $264,000 anyway
Eva Lys had already booked a flight home after failing to qualify for the Australian Open — but scored a second shot at competing after a “lucky loser” spot opened up.
Trump will need to deliver ‘tangible progress’ in his first 100 days for the stock market to go up
Donald Trump’s second presidency is now underway. Here’s a look at how U.S. stocks have fared historically during a new president’s initial months in the White House.
Trump and TikTok: App is still running, but analyst warns of $850 billion hit to companies that help keep it going
While TikTok is operating for existing U.S. users thanks to an executive order signed Monday night by President Donald Trump, analysts are warning that his order doesn’t look all that solid.